Volume 17, Number 9—September 2011
Letter
Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
Table
Factor | No. infections | No. isoniazid- resistant infections | Resistance rate | OR (95% CI) |
---|---|---|---|---|
Patient age, y | ||||
<14 | 42 | 2 | 4.76 | 0.32 (0.08–1.23) |
14 to <24 | 241 | 22 | 9.13 | 0.64 (0.42–1.07) |
24 to <34 | 342 | 36 | 10.53 | 0.75 (0.48–1.18) |
34 to <44 | 384 | 52 | 13.54 | Reference |
44 to <54 | 490 | 56 | 11.43 | 0.82 (0.55–1.23) |
54 to <64 | 609 | 70 | 11.49 | 0.83 (0.57–1.22) |
64 to <74 | 845 | 96 | 11.36 | 0.82 (0.57–1.17) |
74 to <84 | 986 | 85 | 8.62 | 0.60 (0.42–0.87) |
84 |
350 |
28 |
8.00 |
0.56 (0.34–0.90) |
Patient sex | ||||
F | 1,356 | 128 | 9.44 | 0.85 (0.69–1.06) |
M |
2,933 |
319 |
10.88 |
Reference |
Pulmonary tuberculosis | ||||
No | 772 | 56 | 7.25 | 0.63 (0.47–0.84) |
Yes | 3,517 | 391 | 11.12 | Reference |
*OR, odds ratio; CI, confidence interval.
Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.